M. Al-Omary
John Hunter Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by M. Al-Omary.
International Journal of Cardiology | 2017
A. Khan; Asma Ashraf; David Baker; M. Al-Omary; Lindsay Savage; Avedis Ekmejian; R. Singh; Stephen Brienesse; Tazeen Majeed; Tracy Gordon; Vincent Drinkwater; N. Collins
BACKGROUND Clozapine is the cornerstone of therapy for refractory schizophrenia; however, the potential for cardiotoxicity is an important limitation in its use. In the current analysis we sought to evaluate the long term cardiac outcomes of clozapine therapy. METHODS All-cause mortality, incidence of sudden death and time to myocarditis were assessed in a cohort of patients maintained on clozapine between January 2009 and December 2015. All patients had regular electrocardiograms, complete blood count, clozapine levels and echocardiography as part of a formal protocol. RESULTS A total of 503 patients with treatment-resistant schizophrenia were maintained on clozapine during the study period of which 93 patients (18%) discontinued therapy with 29 (6%) deaths. The incidence of sudden death and myocarditis were 2% (n=10) and 3% (n=14) respectively. Amongst patients with sudden death, 7 out of 10 (70%) were documented to have used illicit drugs prior to death, with a tendency to weight gain also noted. The mean time to myocarditis post clozapine commencement was 15±7days. The reduction in left ventricular ejection fraction in those with myocarditis was 11±2%. CONCLUSION Myocarditis and sudden cardiac death are uncommon but clinically important complications in a cohort of patients followed while maintained on clozapine undergoing regular cardiac assessment. Further studies are required to document the role of preventive measures for left ventricular dysfunction and sudden cardiac death in this population.
Heart Lung and Circulation | 2017
M. Al-Omary; A. Davies; A. Khan; M. McGee; Bruce Bastian; James Leitch; John Attia; Peter J. Fletcher; Andrew J. Boyle
BACKGROUND Heart failure carries a major burden on our health system, mainly related to the high rate of hospital admission. An understanding of the recent trends in heart failure hospitalisation is essential to the future allocation of health resources. Our aim is to analyse the temporal trends in heart failure hospitalisation. METHODS We extracted all separations in the Hunter New England Local Health District between 2005-2014 (n=40,119) with an ICD 10 code for heart failure (I-50) in the first four diagnoses on discharge. The numbers of hospitalisations were age-standardised to the 2001 Australian population and compared based on gender and remoteness. RESULTS There was a decline in the age-standardised hospitalisation. However, there was a clear inflection point between 2009-2010, after which the decline levelled off. The absolute number of hospitalisations increased between 2010 and 2014. Heart failure hospitalisation was higher in males compared to females and rural compared to metropolitan inhabitants. CONCLUSION The gains in heart failure treatment noted in recent years seem to have come to an end. Patients aged 75 years and older are contributing the majority of age-standardised hospitalisations.
Internal Medicine Journal | 2017
A. Davies; Crystal Naudin; M. Al-Omary; A. Khan; Christopher Oldmeadow; Mark Jones; Bruce Bastian; Rohan Bhagwandeen; Peter J. Fletcher; James Leitch; Andrew J. Boyle
Trends in the incidence of acute myocardial infarction (AMI) provide important information for healthcare providers and can allow for accurate planning of future health needs and targeted interventions in areas with an excess burden of cardiovascular disease.
Heart Lung and Circulation | 2018
A. Davies; Lloyd Butel-Simoes; Crystal Naudin; M. Al-Omary; A. Khan; Bruce Bastian; Rohan Bhagwandeen; Peter J. Fletcher; James Leitch; Andrew J. Boyle
INTRODUCTION There is conflicting information regarding the contemporary incidence of first acute myocardial infarction (AMI) in Australia. We sought to document the regional variations in first AMI incidence in a large health district. METHODS We identified all patients presenting with first AMI in the Hunter region of New South Wales from 2004 to 2013. We calculated age and gender adjusted incidence of AMI and evaluated differences between patients from regional and metropolitan areas. We assessed 30-day and 12-month outcomes, including mortality, through linkage with the NSW Registry of Births Deaths and Marriages. RESULTS The incidence of first AMI in regional areas was persistently higher throughout the study compared to metropolitan areas (IRR 1.244; 95% CI 1.14-1.35; p≤0.001). There were no significant differences between regional and metropolitan areas in 30-day and 12-month outcomes following presentation with first AMI. CONCLUSIONS The study demonstrates persistently higher rates in regional compared to metropolitan areas, supporting the need for implementation of targeted intervention and prevention strategies.
Esc Heart Failure | 2018
M. Al-Omary; A. Khan; A. Davies; Peter J. Fletcher; Dawn McIvor; Bruce Bastian; Christopher Oldmeadow; Aaron L. Sverdlov; John Attia; Andrew J. Boyle
The aim of the current study is to examine 10 year trends in mortality and readmission following heart failure (HF) hospitalization in metropolitan and regional Australian settings.
Heart Lung and Circulation | 2017
M. Al-Omary; A. Davies; Tiffany-Jane Evans; Bruce Bastian; Peter J. Fletcher; John Attia; Andrew J. Boyle
BACKGROUND Heart failure (HF) is a common, costly condition with an increasing burden on Australian health care system resources. Knowledge of the burden of HF on patients and on the health system is important for resource allocation. This study is the first systematic review to estimate the mortality and readmission rates after hospitalisation for HF in the Australian population. METHODS We searched for studies of HF hospitalisation in Australia published between January 1990 and May 2016, using a systematic search of PubMed, Medline, Scopus, Web of Science, EMBASE and Cochrane Library databases. Studies reporting 30-day and/or 1-year outcomes for mortality or readmission following hospitalisation were eligible and included in this study. RESULTS Out of 2889 articles matching the initial search criteria, a total of 13 studies representing 67,255 patients were included in the final analysis. The pooled mean age of heart failure patients was 76.3 years and 51% were male (n=34,271). The pooled estimated 30-day and 1-year all-cause mortality were 8% and 25% respectively. The pooled estimated 30-day and 1-year all-cause readmission rates were 20% and 56% respectively. There is a high prevalence of comorbidities in heart failure patients. There were limited data on readmission and mortality in rural patients and Indigenous people. CONCLUSIONS Heart failure hospitalisations in Australia are followed by substantial readmission and mortality rates.
Heart Lung and Circulation | 2018
D. Baker; M. Al-Omary; Andrew J. Boyle
Heart Lung and Circulation | 2018
S. Hardy; Andrew J. Boyle; L. Murth; N. Mabotuwana; B. Coulter; Crystal Naudin; P. Rainer; M. Al-Omary
Heart Lung and Circulation | 2018
S. Brienesse; S. Ezad; M. Al-Omary; Aaron L. Sverdlov; Andrew J. Boyle
Heart Lung and Circulation | 2018
S. Sugito; M. McGee; M. Al-Omary; Andrew J. Boyle